Biotech Values

[genisi]

On MYGN's Prolaris test:

In addition, the validation studies were biased towards white males due to the source of the validation material.

From GHDX's abstracts and posters, which indicate patients were mostly caucasians (more than 80%), we can assume the 2 tests aren't so different with regard to this point.